| 摘要 |
<p>A new fibrinogen binding protein or polypeptide originating from coagulase negative staphylococci, biotechnological methods for producing said protein or polypeptide having fibrinogen binding activity and a recombinant DNA molecule coding for said protein (or fragments thereof), and micro-organisms (including viruses) containing this recombinant DNA molecule. The present invention further comprises the therapeutic and diagnostic use of said protein and/or DNA, e.g. a diagnostic kit for determining the presence and/or type of coagulase negative staphylococci and a vaccine composition, comprising said protein or DNA.</p> |
